Cancer | | Disease | Target | Aldo-Keto Reductase Family 1 Member C3 | | | | | | |
ELC | | Target | Target | Ck-beta-11 | | | | | | |
Diabetes | | Disease | Target | CAMK1D | | | | | | |
Cancer | | Disease | Target | CA 15-3 | | | | | | |
CD4 | | Target | Target | CCL27/CTACK | | | | | | |
Kadsurenone | | Drug | Target | Platelet Activating Factor | | | | | | |
D(1a) Dopamine Receptor | | Target | Target | D(2) Dopamine Receptor | | | | | | |
Exodus-2 | | Target | Target | Exodus-3 | | | | | | |
ApoE2 | | Target | Target | APOE | | | | | | |
Angiomax (Bivalirudin)- FDA | | Drug | Target | Bivalirudin | | | | | | |
Alphanate (Antihemophilic Factor)- FDA | | Drug | Target | Collagen | | | | | | |
Diabetes | | Disease | Target | BNP/NPPB | | | | | | |
Glyceraldehyde 3-Phosphate Dehydrogenase | | Target | Target | C1orf41 | | | | | | |
CD4 | | Target | Target | CTLA-4/Fc | | | | | | |
Collagenase-3 | | Target | Target | Collagenase 3 | | | | | | |
Artemin | | Target | Target | Enovin | | | | | | |
Angiotensin Converting Enzyme | | Target | Target | Angiotensin-Converting Enzyme 2 | | | | | | |
Tuberculosis | | Disease | Target | Udp-N-Acetylmuramoylalanine--D-Glutamate Ligase | | | | | | |
Argatroban (Argatroban Injection)- FDA | | Drug | Target | Antithrombin | | | | | | |
Eotaxin | | Target | Target | Eotaxin-3/CCL26 | | | | | | |
Eotaxin | | Target | Target | Eotaxin-2/CCL24 | | | | | | |
Neutral Alpha-Glucosidase C | | Target | Target | Alpha-Glucosidase | | | | | | |
Alpha-Glucosidase | | Target | Target | Lysosomal Alpha-Glucosidase | | | | | | |
BNP | | Target | Target | BNP/NPPB | | | | | | |
Argatroban Injection (Argatroban)- FDA | | Drug | Target | Antithrombin | | | | | | |
Shock | | Disease | Target | C1orf41 | | | | | | |
Alpha-Amylase | | Target | Target | Pancreatic Alpha-Amylase | | | | | | |
CXCL10/IP-10 | | Target | Target | CXCL10 | | | | | | |
Antihemophilic Factor (Alphanate)- FDA | | Drug | Target | Collagen | | | | | | |
Metabotropic Glutamate Receptor 1 | | Target | Target | Glutamate Receptor 1 | | | | | | |